Muse Bio
Muse.Bio
- Business Model
- B2B
- Website
- mycells.bio
- Total Funding
- $24.1M
- Last Round
- $1.1M Pre-SeedFeb 2025
- Rounds
- 2
About
Muse Bio is a stem cell research company studying menstrual blood-derived stem cells for regenerative medicine and therapeutic development.
Summary
Muse Bio is a Biotech company. It has raised $24.1M in total across 2 rounds, most recently a $1.1M Pre-Seed round in Feb 2025. Investors include Draper Associates, Venrock and Foresite Capital.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...